Clinical Trial

Rocklatan Retinal Perfusion OCT Study

Name: Rocklatan Retinal Perfusion OCT Study — clinical trial record (NCT07174401)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The main purpose of this study is to learn more about how Rocklatan eye drops affects blood flow in the eye. The secondary purpose is to see if our study devices can detect changes in blood flow before and after instillation of Rocklatan.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-12.

Trial Details

NCT Number	NCT07174401
Lead Sponsor	Oregon Health and Science University Collaborators: Alcon Research
Conditions	Glaucoma
Enrollment	30 participants
Start Date	2026-01
Primary Completion	2026-12 (estimated)
Study Completion	2027-10 (estimated)
Updated on ClinicalTrials.gov	2025-12-24